Literature DB >> 25243621

Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.

S Bhaskaran1, R F Abu-Arja2, G Abusin3, L Cabral1, K Nagle1, S Ahuja1, R Egler1, K R Cooke4, H M Lazarus5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25243621     DOI： 10.1038/bmt.2014.205

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor.

Authors:  Akos Czibere; Ingmar Bruns; Thorsten Graef; Roland Fenk; Fabian Zohren; Nancy Safaian; Mirko Mueller; Rainer Haas; Guido Kobbe
Journal:  Biol Blood Marrow Transplant       Date:  2007-05-23       Impact factor: 5.742

Review 2.  Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children.

Authors:  Zuzana Hassan
Journal:  Pediatr Transplant       Date:  2011-04-19

3.  Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis.

Authors:  T R Ulich; L Whitcomb; W Tang; P O'Conner Tressel; J Tarpley; E S Yi; D Lacey
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  Keratinocyte growth factor causes proliferation of urothelium in vivo.

Authors:  E S Yi; A S Shabaik; D L Lacey; A A Bedoya; S Yin; R M Housley; D M Danilenko; W Benson; A M Cohen; G F Pierce
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450
  4 in total
  1 in total

1.  Canadian Urological Association Best Practice Report: Pediatric hemorrhagic cystitis.

Authors:  Jessica H Hannick; Martin A Koyle
Journal:  Can Urol Assoc J       Date:  2019-11       Impact factor: 1.862
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.